11.2 Medication Handling, Delivery, and Calculations on the Sterile Field

11.2 Medication Handling, Delivery, and Calculations on the Sterile Field

Medication administration in the perioperative environment represents one of the most critical safety responsibilities shared between the circulator and the certified surgical technologist (CST). Unlike conventional inpatient floors where multiple automated checks exist before a nurse administers a drug, the sterile field requires real-time precision in transferring, measuring, diluting, labeling, and passing potent pharmaceuticals directly to the operating surgeon.

For the Tech in Surgery - Certified (NCCT TS-C) examination, medication delivery, dosage calculations, and sterile field pharmacology are heavily tested in the Perioperative Care Basic Science task area (drug uses, effects, and complications; the "Rights" of medication administration), the Communication and Reporting task (label medications and solutions appropriately), and End of Procedure Tasks (report totals of medications and solutions used). The CST must maintain zero tolerance for error, strictly upholding the Six Rights of Medication Administration, Joint Commission labeling mandates, and absolute mathematical accuracy.

---

1. The "Six Rights" and Aseptic Medication Transfer Protocols

Every medication accepted onto the sterile field must satisfy the fundamental Six Rights of Perioperative Medication Administration:

1. Right Patient: Verified during the pre-procedure Time-Out.
2. Right Drug: Generic and trade names checked against the surgeon's preference card and operative order.
3. Right Dose / Concentration: Strength, percentage, and total volume verified.
4. Right Route: Route specified (e.g., local infiltration, topical, intra-articular, irrigation; never IV by CST).
5. Right Time / Frequency: Administered at the correct surgical step.
6. Right Documentation: Exact drug name, concentration, volume received, volume administered, and volume remaining accurately reported to the circulator at case conclusion.

+-----------------------------------------------------------------------------+
|                  MEDICATION TRANSFER & VERIFICATION WORKFLOW                |
|                                                                             |
|   1. CIRCULATOR HOLDS VIAL & READS ALOUD:                                   |
|      - Drug Name, Concentration, Expiration Date, Route/Purity              |
|                                                                             |
|   2. CST VISUALLY INSPECTS VIAL & REPEATS ALOUD:                            |
|      - Confirms details match verbal statement and preference card          |
|                                                                             |
|   3. ASEPTIC TRANSFER VIA STERILE DEVICE:                                   |
|      - Sterile vial spike, transfer decanter, or filtered needle draw       |
|      - Never touch unsterile vial exterior; maintain 12-inch air boundary   |
|                                                                             |
|   4. IMMEDIATE STERILE FIELD LABELING:                                      |
|      - Medication basin/cup AND syringe labeled immediately                 |
|                                                                             |
|   5. PASSING TO SURGEON WITH VERBAL CONFIRMATION:                           |
|      - State aloud: "Lidocaine 1% with Epinephrine 1:100,000, 10 mL"        |
+-----------------------------------------------------------------------------+

Dual-Verification Protocol (Step-by-Step)

1. First Check (Circulator): The circulator obtains the medication from pharmacy storage, verifying the vial label against the surgeon's preference card and patient chart.
2. Second Check (Joint Verification): The circulator presents the vial to the CST. Both the circulator and the CST read the vial label aloud together, confirming:
   • Full Generic and Trade Name
   • Strength and Concentration (e.g., $1%$, $0.5%$, $500\text{ mg/mL}$)
   • Expiration Date and Lot Number
   • Special properties (e.g., with or without Epinephrine, preservative-free)
   • Integrity of the container and absence of particulate matter or discoloration
3. Third Check (Post-Transfer): The medication is transferred onto the sterile field using an aseptic transfer technique. The circulator holds the vial while the CST withdraws the medication using a sterile syringe with an 18-gauge blunt fill needle, or the circulator dispenses the solution via a sterile vial spike or decanter straw.
4. Fourth Check (Passing to Surgeon): When the CST hands the medication-filled syringe to the surgeon, the CST states the medication name and concentration aloud (e.g., "Here is 1% Lidocaine plain, 10 mL").

Aseptic Transfer Rules

• Never Reach Over Basins: The circulator must never reach over the sterile field or hover directly above open sterile containers.
• No Vial De-capping: Rubber stoppers must not be removed from vials to pour contents, as pouring over the unsterile glass lip risks fluid contamination.
• Needle Safety & Recapping: Recapping contaminated needles using two hands is strictly prohibited by OSHA. If recapping is necessary on the back table, utilize the one-handed scoop technique or an engineered passive needle recapping block device.

---

2. Sterile Field Labeling Mandates and Safety Standards

[!IMPORTANT] The Joint Commission National Patient Safety Goal (NPSG.03.04.01): All medications, medication containers (e.g., syringes, medicine cups, basins, squeeze bottles), and other solutions on and off the sterile field must be labeled immediately upon preparation or transfer if not immediately administered by the individual who prepared it.

Required Label Information

Every sterile field label must include:

• Medication Name (Generic and/or Brand Name)
• Concentration / Strength (e.g., $0.25%$, $10\text{ mg/mL}$)
• Amount / Total Volume (if applicable)
• Date and Time of preparation/opening
• Expiration Date (if dated for less than 24 hours)
• Initials of the CST who prepared the solution

+-----------------------------------------------------------------------------+
|                        SAMPLE STERILE FIELD DRUG LABEL                      |
|                                                                             |
|   DRUG:  Bupivacaine HCl (Marcaine) 0.5% with Epi 1:200,000                 |
|   DOSE:  5 mg/mL (Total Vol: 30 mL)                                         |
|   DATE:  2026-08-19                TIME: 08:30 AM                           |
|   EXP:   24 Hours                  PREPARED BY: RC, CST                     |
+-----------------------------------------------------------------------------+

Management of Unlabeled Solutions

If any syringe, basin, or container is found unlabeled on the sterile back table or Mayo stand—even for a brief moment—it is considered contaminated. It must be immediately discarded along with the container and syringe, and fresh medication must be obtained and verified from the start.

---

3. Surgical Dosage Calculations and Metric Conversions

The surgical technologist must perform rapid, flawless mathematical conversions to verify drug dosages, calculate dilution strengths, and prevent fatal overdoses.

Metric System Foundations

+-----------------------------------------------------------------------------+
|                         METRIC CONVERSION CONSTANTS                         |
|                                                                             |
|   1 Kilogram (kg)      = 1,000 Grams (g)       = 2.2046 Pounds (lbs)        |
|   1 Gram (g)           = 1,000 Milligrams (mg)                              |
|   1 Milligram (mg)     = 1,000 Micrograms (mcg / µg)                        |
|   1 Liter (L)          = 1,000 Milliliters (mL) = 1,000 Cubic Centimeters   |
|   1 Fluid Ounce (fl oz)= 30 Milliliters (mL) (approx. 29.57 mL)             |
|   1 Teaspoon (tsp)     = 5 Milliliters (mL)                                 |
|   1 Tablespoon (tbsp)  = 15 Milliliters (mL)                                |
+-----------------------------------------------------------------------------+

1. Percentage Solution Calculations

In pharmaceutical formulations, a percentage solution expresses the weight of solute in grams per $100\text{ mL}$ of liquid solution:

$\text{Percentage (\%)} = \frac{\text{Grams of Solute}}{100\text{ mL of Solution}}$

• The "Multiply by 10" Rule: To convert a percentage concentration to milligrams per milliliter ($\text{mg/mL}$), multiply the percentage value by 10. $\text{Concentration (mg/mL)} = \text{Percentage (\%)} \times 10$

Examples:

• $1%$ Lidocaine: $1 \times 10 = 10\text{ mg/mL}$. A $30\text{ mL}$ vial contains $10\text{ mg/mL} \times 30\text{ mL} = 300\text{ mg}$.
• $2%$ Lidocaine: $2 \times 10 = 20\text{ mg/mL}$. A $20\text{ mL}$ vial contains $20\text{ mg/mL} \times 20\text{ mL} = 400\text{ mg}$.
• $0.5%$ Bupivacaine (Marcaine): $0.5 \times 10 = 5\text{ mg/mL}$. A $30\text{ mL}$ vial contains $5\text{ mg/mL} \times 30\text{ mL} = 150\text{ mg}$.
• $0.25%$ Bupivacaine: $0.25 \times 10 = 2.5\text{ mg/mL}$. A $50\text{ mL}$ bottle contains $2.5\text{ mg/mL} \times 50\text{ mL} = 125\text{ mg}$.

2. Ratio Strength Solutions (Epinephrine Concentrations)

A ratio expresses parts of drug per parts of solution (e.g., $1:1,000$ represents $1\text{ g}$ of drug in $1,000\text{ mL}$ of solution):

3. Dilution Equation ($C_1V_1 = C_2V_2$)

When preparing a diluted solution from a concentrated stock solution: $C_1 \times V_1 = C_2 \times V_2$ Where:

• $C_1 =$ Initial stock concentration
• $V_1 =$ Initial volume of stock solution needed
• $C_2 =$ Final desired concentration
• $V_2 =$ Final total volume of diluted solution

Clinical Calculation Example: The surgeon requests $100\text{ mL}$ of $0.5%$ Lidocaine. You only have $2%$ Lidocaine stock on hand. How much $2%$ Lidocaine and how much sterile saline must you mix? $C_1 \times V_1 = C_2 \times V_2 \implies 2\% \times V_1 = 0.5\% \times 100\text{ mL}$ $V_1 = \frac{0.5 \times 100}{2} = \frac{50}{2} = 25\text{ mL}$ Solution: Draw $25\text{ mL}$ of $2%$ Lidocaine and mix with $75\text{ mL}$ of sterile normal saline ($100\text{ mL} - 25\text{ mL} = 75\text{ mL}$) to yield $100\text{ mL}$ of $0.5%$ Lidocaine.

4. Maximum Safe Dosage Calculations

Local anesthetics have strict weight-based toxic thresholds:

Clinical Calculation Example: What is the maximum safe volume of $1%$ Lidocaine with Epinephrine ($1:100,000$) that can be administered to a $70\text{ kg}$ adult patient?

1. Calculate max dose in mg: $70\text{ kg} \times 7\text{ mg/kg} = 490\text{ mg}$ (below the absolute $500\text{ mg}$ cap).
2. Calculate mg/mL of $1%$ solution: $1 \times 10 = 10\text{ mg/mL}$.
3. Calculate volume in mL: $\frac{490\text{ mg}}{10\text{ mg/mL}} = 49\text{ mL}$.

---

4. Comprehensive Sterile Field Pharmacology Matrix

1. Local Anesthetics (Amides vs. Esters)

• Amides (contain two letter "i"s in generic name): Lidocaine, Bupivacaine, Ropivacaine, Mepivacaine. Metabolized primarily by hepatic microsomal enzymes in the liver; low incidence of true allergic hypersensitivity.
• Esters (contain one letter "i" in generic name): Cocaine, Procaine (Novocain), Tetracaine (Pontocaine). Metabolized in plasma by pseudocholinesterase; higher allergic potential due to the metabolite para-aminobenzoic acid (PABA).
  • Cocaine Hydrochloride (4% / 10% topical): The only local anesthetic that produces intrinsic vasoconstriction by blocking norepinephrine reuptake. Strictly used topically on mucous membranes in ENT surgery (rhinoplasty, septoplasty); strictly prohibited from systemic or local injection (fatal hypertension/arrhythmias).
• Role of Epinephrine in Local Infiltration:
  • Vasoconstricts local microvasculature -> minimizes operative bleeding.
  • Slows systemic absorption -> reduces peak plasma drug levels and toxicity.
  • Prolongs duration of the local anesthetic block by up to 50–100%.
  • Absolute Contraindications: Areas supplied by end-arteries with no collateral flow (digits of fingers/toes, penis, tip of nose, earlobes) due to severe risk of vasospasm, tissue ischemia, and gangrene.

2. Topical Hemostatic Agents

+-----------------------------------------------------------------------------+
|                         TOPICAL HEMOSTAT TAXONOMY                           |
|                                                                             |
|   MECHANICAL MATRICES  -> Gelfoam, Surgicel, Oxycel, Avitene                |
|   ACTIVE ENZYMATIC     -> Topical Thrombin (Bovine, Recombinant)            |
|   FLOWABLE AGENTS      -> FloSeal, Surgiflo (Gelatin granules + Thrombin)   |
|   FIBRIN SEALANTS      -> Tisseel, Evicel (Fibrinogen + Thrombin)           |
|   CHEMICAL CAUTERANTS  -> Silver Nitrate, Monsel's Solution (Ferric Subsulf)|
+-----------------------------------------------------------------------------+

• Absorbable Gelatin (Gelfoam / Surgifoam): Porous animal-skin collagen matrix that absorbs 40–50 times its weight in blood, promoting platelet entrapment. Absorbed in 4–6 weeks. Frequently soaked in Topical Thrombin.
• Oxidized Regenerated Cellulose (Surgicel / Nu-Knit / Fibrillar): Plant cellulose treated with nitrogen dioxide; turns into an acidic dark gelatinous mass upon contact with blood, activating extrinsic clotting and exerting intrinsic antibacterial properties. Absorbed in 7–14 days. Must be removed from bony or neural foramina to prevent compression edema.
• Microfibrillar Collagen Hemostat (MCH / Avitene): Dry, fluffy fibrous collagen derived from bovine corium. Applied strictly dry with dry forceps directly onto bleeding oozing surfaces, triggering platelet aggregation and instantaneous clot formation. Avoid applying to skin edges as it inhibits wound healing.
• Topical Thrombin (Evithrom / Recothrom): Lyophilized active clotting factor IIa (converts fibrinogen directly to fibrin). Reconstituted with sterile saline.

[!CAUTION] Topical Thrombin Warning: Thrombin is formulated STRICTLY FOR TOPICAL APPLICATION ONLY. Never inject Thrombin into vascular lumens, arteries, or veins. Inadvertent intravascular injection causes instantaneous, catastrophic, widespread intravascular coagulation (DIC) and immediate death.

3. Anticoagulants and Emergency Reversal Agents

• Heparin Sodium: Parenteral anticoagulant that binds antithrombin III, inactivating Thrombin (Factor IIa) and Factor Xa, preventing clot formation.
  • Vascular Surgery Dosing: Systemic bolus (100–300 units/kg) before arterial clamping; topical vascular flush (5,000 units in 1,000 mL normal saline = 5 units/mL).
• Protamine Sulfate: Specific antagonist and reversal agent for Heparin. A positively charged alkaline protein derived from salmon sperm that forms a stable, inactive neutral salt complex with negatively charged acidic heparin.
  • Dosing: $1\text{ mg}$ Protamine neutralizes approximately $100\text{ units}$ of circulating Heparin.
  • Administration Caution: Must be infused slowly IV over 10 minutes; rapid injection causes profound systemic hypotension, acute pulmonary vasoconstriction, and fatal anaphylactoid shock.
• Tranexamic Acid (TXA): Synthetic lysine-analogue antifibrinolytic agent that competitively inhibits plasminogen activation to plasmin, preventing premature clot breakdown. Widely used in orthopedic arthroplasty, trauma, and cardiac surgery to reduce blood loss and transfusion requirements.

4. Radiopaque Contrast Media and Diagnostic Dyes

5. Surgical Irrigation Solutions and Distension Media

• 0.9% Sodium Chloride (Normal Saline): Isotonic ($308\text{ mOsm/L}$), standard for general wound irrigation, peritoneal cavity washing, and moistening sponges/cottonoids. Conductive: contraindicated with monopolar electrosurgery in endoscopic fluid cavities.
• Sterile Water for Irrigation: Hypotonic ($0\text{ mOsm/L}$); causes rapid osmotic cell lysis. Used in cancer resection beds (to lyse shed neoplastic tumor cells) and during Transurethral Resection of Bladder Tumor (TURBT). Hazard: Intravascular absorption in large volumes causes severe hemolysis and fatal hyponatremia; never used for cell saver autotransfusion washing.
• Non-Electrolytic Distension Solutions (Glycine 1.5%, Sorbitol 3%, Mannitol): Non-conductive fluids utilized to distend the bladder during monopolar Transurethral Resection of the Prostate (TURP) or the uterus during hysteroscopy without dissipating electrical current.
  • Complication: TURP Syndrome (Fluid Overload / Dilutional Hyponatremia): Absorption of large volumes of non-electrolytic fluid through opened venous sinuses causing hypervolemic heart failure, pulmonary edema, severe hyponatremia ($Na^+ < 120\text{ mEq/L}$), cerebral edema, seizures, and visual disturbances.